Edge Medical Ventures

Edge Medical Ventures (EdgeMed) is a medtech-focused venture capital firm and venture studio founded in 2024 by the leadership team of MEDX Xelerator, Israel's leading medical device incubator. The firm operates two complementary arms: EdgeLabs, a venture creation studio that builds companies from validated clinical unmet needs in collaboration with strategic partners; and EdgeMED, a later-stage fund that invests $1M–$3M per company at the clinical stage, primarily in Seed, Series A, and early Series B rounds, with $5M–$6M reserved for follow-on investments per company. The fund targets a total size of $70M and completed an initial close of approximately $20M in September 2024. Areas of interest include breakthrough medical device technologies in vascular interventions, urology, gastrointestinal, women's health, home treatment, imaging, and minimally invasive surgery. A core strategic focus is bridging Israeli medtech innovation to the U.S. market, including support for clinical operations, commercial launch preparation, and U.S. office establishment. The firm has dual headquarters in Or Yehuda, Israel and Jersey City, New Jersey. Founders can apply by emailing a pitch deck and one-pager to info@edgemed.vc.